| 1 |
35022320 | BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma. | 2022 Mar 15 |
1 |
| 2 |
35156519 | Clinical trial results show promise of targeting autophagy BRAF mutant melanoma. | 2022 Jun |
1 |
| 3 |
29324592 | FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Results From a Phase I/II Clinical Treatment Trial. | 2019 Mar |
1 |